0403 GMT - Navigator Global Investments' solid March quarter and broadly unchanged annual guidance help support a continued bullish view of the stock at Morgans. Maintaining a buy rating on the stock, analyst Richard Coles trims his EPS estimate for the current fiscal year by 3% to reflect his more conservative performance fee assumptions. However, he lifts his funds-under-management estimates following a 9% rise across the last quarter, driving a 2% lift in his EPS forecast for fiscal 2027. He tells clients in a note that the Australian alternative asset manager also appears to be trying to reassure investors over the status of the 46% stake in the business held by Blue Owl, clarifying that it is managed on behalf of institutional partners. Morgans trims its target price 0.3% to A$2.97. Shares are up 2.9% at A$2.50. (stuart.condie@wsj.com)

(END) Dow Jones Newswires

April 21, 2026 00:03 ET (04:03 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.